Trust Company of the Ozarks’s Pfizer PFE Stock Holding History

Trust Company of the Ozarks’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$1.48M	Sell	49,555 -1,634	-3%	-$52.4K	0.51%	43
2015 Q2	$1.63M	Sell	51,189 -68	-0.1%	-$2.22K	0.45%	40
2015 Q1	$1.69M	Sell	51,257 -1,496	-3%	-$47.6K	0.45%	36
2014 Q4	$1.56M	Buy	52,753 +2,752	+6%	+$78.9K	0.43%	41
2014 Q3	$1.4M	Buy	50,001 +1,538	+3%	+$43.2K	0.4%	46
2014 Q2	$1.36M	Sell	48,463 -5,169	-10%	-$147K	0.37%	47
2014 Q1	$1.63M	Buy	53,632 +2,786	+5%	+$83.1K	0.46%	33
2013 Q4	$1.48M	Sell	50,846 -2,834	-5%	-$82.5K	0.42%	39
2013 Q3	$1.46M	Buy	53,680 +2,823	+6%	+$76.8K	0.46%	38
2013 Q2	$1.35M	Buy	+50,857	New	+$1.41M	0.45%	43

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Trust Company of the Ozarks's PFE Position: Q3 2015 in Review

Trust Company of the Ozarks reduced its Pfizer (PFE) stake by 3.2% in Q3 2015, selling an estimated $52.4K and leaving 49,555 shares worth $1.48M. The position accounts for 0.51% of the portfolio, ranked #43.

Trust Company of the Ozarks first reported a position in PFE in Q2 2013 and has held it in 10 quarters since. The position peaked at $1.69M in Q1 2015. 1,880 funds tracked by Wall St. Rank hold PFE as of Q3 2015.

Trust Company of the Ozarks held 49,555 shares of Pfizer worth $1.48M as of Q3 2015.
Trust Company of the Ozarks sold 1,634 Pfizer shares in Q3 2015, an estimated $52.4K.
Pfizer made up 0.51% of Trust Company of the Ozarks's portfolio in Q3 2015, its #43 holding.
Trust Company of the Ozarks first reported a position in Pfizer in Q2 2013 and has held it in 10 quarters since.
Trust Company of the Ozarks's Pfizer position peaked at $1.69M in Q1 2015.
1,880 funds tracked by Wall St. Rank held Pfizer as of Q3 2015.

Based on Trust Company of the Ozarks's 13F filing for Q3 2015, filed 4 Nov 2015.